{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:23:53Z","timestamp":1761157433042,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10072-022-06451-8","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:02:50Z","timestamp":1666396970000},"page":"593-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of motor neuron diseases in gout patients: a nationwide population-based cohort study"],"prefix":"10.1007","volume":"44","author":[{"given":"Hyuk Sung","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeonjae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Bum","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sojeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Ryong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-4423","authenticated-orcid":false,"given":"Hojin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,22]]},"reference":[{"key":"6451_CR1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3988\/jcn.2015.11.4.376","volume":"11","author":"SI Oh","year":"2015","unstructured":"Oh SI, Baek S, Park JS, Piao L, Oh KW, Kim SH (2015) Prognostic role of serum levels of uric acid in amyotrophic lateral sclerosis. J Clin Neurol 11:376\u2013382","journal-title":"J Clin Neurol"},{"key":"6451_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","volume":"17","author":"VL Feigin","year":"2018","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N et al (2018) Global, regional, and national burden of motor neuron diseases 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:1083\u20131097","journal-title":"Lancet Neurol"},{"key":"6451_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/occmed\/kqab180","volume":"72","author":"T Sorahan","year":"2022","unstructured":"Sorahan T, Nichols L (2022) Motor neuron disease risk and magnetic field exposures. Occup Med 72:184\u2013190","journal-title":"Occup Med"},{"key":"6451_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chi\u00f2","year":"2013","unstructured":"Chi\u00f2 A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA et al (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiol 41:118\u2013130","journal-title":"Neuroepidemiol"},{"key":"6451_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12877-018-0975-0","volume":"18","author":"JA Singh","year":"2018","unstructured":"Singh JA, Cleveland JD (2018) Gout and dementia in the elderly: a cohort study of Medicare claims. BMC Geriatr 18:281","journal-title":"BMC Geriatr"},{"key":"6451_CR6","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and Nutrition Examination Survey. JAMA 283:2404\u20132410","journal-title":"JAMA"},{"issue":"Pt 1","key":"6451_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/bj3400143","volume":"340","author":"M Bagnati","year":"1999","unstructured":"Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G (1999) When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 340(Pt 1):143\u2013152","journal-title":"Biochem J"},{"key":"6451_CR8","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11:4145\u20134151","journal-title":"Curr Pharm Des"},{"key":"6451_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/abbi.2000.1721","volume":"376","author":"GL Squadrito","year":"2000","unstructured":"Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM et al (2000) Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 376:333\u2013337","journal-title":"Arch Biochem Biophys"},{"key":"6451_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s13311-016-0497-4","volume":"14","author":"S Paganoni","year":"2017","unstructured":"Paganoni S, Schwarzschild MA (2017) Urate as a marker of risk and progression of neurodegenerative disease. Neurotherapeutics 14:148\u2013153","journal-title":"Neurotherapeutics"},{"key":"6451_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41598-018-19609-2","volume":"8","author":"F Zhang","year":"2018","unstructured":"Zhang F, Zhang Q, Ke Y, Hao J, Lu L, Lu N et al (2018) Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis. Sci Rep 8:1100","journal-title":"Sci Rep"},{"key":"6451_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.20663","volume":"58","author":"LM de Lau","year":"2005","unstructured":"de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2005) Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 58:797\u2013800","journal-title":"Ann Neurol"},{"key":"6451_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/annrheumdis-2014-206917","volume":"75","author":"N Lu","year":"2016","unstructured":"Lu N, Dubreuil M, Zhang Y, Neogi T, Rai SK, Ascherio A et al (2016) Gout and the risk of Alzheimer\u2019s disease: a population-based, BMI-matched cohort study. Ann Rheum Dis 75:547\u2013551","journal-title":"Ann Rheum Dis"},{"key":"6451_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jbmr.2978","volume":"32","author":"SC Kim","year":"2017","unstructured":"Kim SC, Paik JM, Liu J, Curhan GC, Solomon DH (2017) Gout and the risk of non-vertebral fracture. J Bone Miner Res 32:230\u2013236","journal-title":"J Bone Miner Res"},{"key":"6451_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/jnnp-2018-318974","volume":"90","author":"KY Jun","year":"2019","unstructured":"Jun KY, Park J, Oh KW, Kim EM, Bae JS, Kim I et al (2019) Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry 90:395\u2013403","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6451_CR16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57:1288\u20131294","journal-title":"J Clin Epidemiol"},{"key":"6451_CR17","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/acn3.671","volume":"5","author":"K Nicholson","year":"2018","unstructured":"Nicholson K, Chan J, Macklin EA, Levine-Weinberg M, Breen C, Bakshi R et al (2018) Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 5:1522\u20131533","journal-title":"Ann Clin Transl Neurol"},{"key":"6451_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/17482968.2011.610110","volume":"13","author":"C Moreau","year":"2012","unstructured":"Moreau C, Brunaud-Danel V, Dallongeville J, Duhamel A, Laurier-Grymonprez L, de Reuck J et al (2012) Modifying effect of arterial hypertension on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13:194\u2013201","journal-title":"Amyotroph Lateral Scler"},{"key":"6451_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jocn.2021.12.021","volume":"96","author":"K Xu","year":"2021","unstructured":"Xu K, Ji H, Hu N (2021) Cardiovascular comorbidities in amyotrophic lateral sclerosis: a systematic review. J Clin Neurosci 96:43\u201349","journal-title":"J Clin Neurosci"},{"key":"6451_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1756-0500-7-171","volume":"7","author":"A Lekoubou","year":"2014","unstructured":"Lekoubou A, Matsha TE, Sobngwi E, Kengne AP (2014) Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review. BMC Res Notes 7:171","journal-title":"BMC Res Notes"},{"key":"6451_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1212\/WNL.0b013e3182a6cc13","volume":"81","author":"MR Turner","year":"2013","unstructured":"Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ (2013) Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurol 81:1222\u20131225","journal-title":"Neurol"},{"key":"6451_CR22","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/ene.12632","volume":"22","author":"D Mariosa","year":"2015","unstructured":"Mariosa D, Kamel F, Bellocco R, Ye W, Fang F (2015) Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur J Neurol 22:1436\u20131442","journal-title":"Eur J Neurol"},{"key":"6451_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/ene.13465","volume":"25","author":"F D'Ovidio","year":"2018","unstructured":"D\u2019Ovidio F, d\u2019Errico A, Carn\u00e0 P, Calvo A, Costa G, Chi\u00f2 A (2018) The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis. Eur J Neurol 25:164\u2013170","journal-title":"Eur J Neurol"},{"key":"6451_CR24","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10072-021-05099-0","volume":"42","author":"R Vasta","year":"2021","unstructured":"Vasta R, D\u2019Ovidio F, Logroscino G, Chi\u00f2 A (2021) The links between diabetes mellitus and amyotrophic lateral sclerosis. Neurol Sci 42:1377\u20131387","journal-title":"Neurol Sci"},{"key":"6451_CR25","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R et al (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurol 70:1004\u20131009","journal-title":"Neurol"},{"key":"6451_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.25431","volume":"85","author":"S Bandres-Ciga","year":"2019","unstructured":"Bandres-Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G et al (2019) Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol 85:470\u2013481","journal-title":"Ann Neurol"},{"key":"6451_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/21678421.2012.732078","volume":"14","author":"Z Zheng","year":"2013","unstructured":"Zheng Z, Sheng L, Shang H (2013) Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener 14:241\u2013245","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"6451_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s13760-021-01753-8","volume":"122","author":"F Nabizadeh","year":"2022","unstructured":"Nabizadeh F, Balabandian M, Sharafi AM, Ghaderi A, Rostami MR, Naser Moghadasi A (2022) Statins and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. Acta Neurol Belg 122:979\u2013986","journal-title":"Acta Neurol Belg"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06451-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06451-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06451-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T07:12:50Z","timestamp":1673853170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06451-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,22]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["6451"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06451-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2022,10,22]]},"assertion":[{"value":"24 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Hanyang University Guri Hospital (2020\u201301\u2013025) and registered at the clinical research information service (CRIS) under the registration number KCT0006241.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All personal information in the HIRA database was de-identified, and the requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}